Am. J. Respir. Cell Mol. Biol., Volume 22, Number 4, April, 2000 481-490

Local Activation of Nonspecific Defense against a Respiratory Model Infection by Application of Interferon-
Comparison between Rat Alveolar and Interstitial Lung Macrophages

Christiane Steinmüller, Gabriela Franke-Ullmann, Marie-Luise Lohmann-Matthes, and Andreas Emmendörffer

Deutsches Zentrum für Luft- und Rahmfahrt, Projektträger des BMBF Gesundheitsforschung, Bonn; and Abteilung Immunbiologie, Fraunhofer Institut für Toxikologie und Aerosolforschung, Hannover, Germany

Pulmonary macrophages play a crucial role in the defense of inhaled pathogens. We characterized functional properties of alveolar (AM) and interstitial (IM) macrophages from rats. AM exhibited a pronounced microbicidal capacity as shown by an elevated production of reactive oxygen intermediates (ROI), nitric oxide (NO), tumor necrosis factor (TNF)-, and tumor cytotoxicity when compared with IM. In contrast, IM were superior to AM regarding mechanisms mainly involved in the induction and maintenance of specific immune reactions (major histocompatibility complex [MHC] class II expression, interleukin [IL]-1 and IL-6). In this line, we were interested in whether the microbicidal potential of AM could be augmented by treating Lewis rats with rat recombinant interferon (IFN)- (5 × 10² to 1 × 10⁵ U/animal) intratracheally, avoiding infection of interstitial lung macrophages or other organ-associated macrophages. The pulmonary cytokine application resulted in an activation of AM when macrophages from IFN-treated animals were compared with control macrophages from saline-treated rats 18 h after the treatment: (1) mediator release (ROI, NO, TNF-, IL-6), (2) tumoricidal activity; (3) dose-dependent increase of MHC class II expression. The local immunomodulation enhanced the resistance of normal and immunosuppressed rats against respiratory infections with Listeria monocytogenes. Taken together, local activation of lung macrophages is a feasible therapeutic strategy against pulmonary infections.

This article has been cited by other articles:

				J. Padilla, E. Daley, A. Chow, K. Robinson, K. Parthasarathi, A. N. J. McKenzie, T. Tschernig, V. P. Kurup, D. D. Donaldson, and G. Grunig IL-13 Regulates the Immune Response to Inhaled Antigens J. Immunol., June 15, 2005; 174(12): 8097 - 8105. [Abstract] [Full Text] [PDF]

				R. M. Wright, L. A. Ginger, N. Kosila, N. D. Elkins, B. Essary, J. L. McManaman, and J. E. Repine Mononuclear Phagocyte Xanthine Oxidoreductase Contributes to Cytokine-Induced Acute Lung Injury Am. J. Respir. Cell Mol. Biol., April 1, 2004; 30(4): 479 - 490. [Abstract] [Full Text] [PDF]

				M. Wu, S. Hussain, Y.-H. He, R. Pasula, P. A. Smith, and W. J. Martin II Genetically engineered macrophages expressing IFN-gamma restore alveolar immune function in scid mice PNAS, November 20, 2001; (2001) 251451498. [Abstract] [Full Text] [PDF]

				D. L. Laskin, B. Weinberger, and J. D. Laskin Functional heterogeneity in liver and lung macrophages J. Leukoc. Biol., August 1, 2001; 70(2): 163 - 170. [Abstract] [Full Text] [PDF]

				T. Bernier, T. Tschernig, R. Pabst, O. Macke, C. Steinmueller, and A. Emmendorffer Effects of macrophage-CSF on pulmonary-macrophage repopulation after bone marrow transplantation J. Leukoc. Biol., July 1, 2001; 70(1): 39 - 45. [Abstract] [Full Text] [PDF]

				M. Wu, S. Hussain, Y.-H. He, R. Pasula, P. A. Smith, and W. J. Martin II Genetically engineered macrophages expressing IFN-gamma restore alveolar immune function in scid mice PNAS, December 4, 2001; 98(25): 14589 - 14594. [Abstract] [Full Text] [PDF]